What is the characteristic appearance of subarachnoid hemorrhage on a plain Computed Tomography (CT) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristic Appearance of Subarachnoid Hemorrhage on Plain CT Scan

Subarachnoid hemorrhage appears on non-contrast CT as hyperdense (bright white) blood filling the basal cisterns, following the contour of sulci and gyri, and layering in the Sylvian fissures and convexity sulci. 1

Primary CT Characteristics

Acute Phase Appearance (First 3 Days)

  • Blood appears as hyperdense material (brighter than normal brain tissue) distributed in the subarachnoid spaces, with CT sensitivity approaching 100% within the first 3 days after onset 1
  • Classic distribution patterns include:
    • Blood in the basal cisterns (most common location) 1
    • Blood following the contour of sulci and gyri (distinguishes it from subdural hematoma) 1
    • Blood in the Sylvian fissures 1
    • Blood in the convexity sulci 1
    • Blood may layer in gravity-dependent locations such as the occipital horn of the lateral ventricle 1

Distribution Patterns by Etiology

Aneurysmal SAH typically shows:

  • Diffuse blood distribution or blood concentrated around the circle of Willis 2
  • May completely fill the lateral Sylvian or anterior interhemispheric fissures 3
  • Can extend into the ventricular system 2

Perimesencephalic (non-aneurysmal) SAH shows a distinct pattern:

  • Blood centered immediately anterior to the brainstem 3
  • May extend to ambient cisterns or basal parts of Sylvian fissures 3
  • Lateral Sylvian or anterior interhemispheric fissures are never completely filled 3
  • No intraventricular extension 3
  • This pattern has a 95% predictive value for negative angiography and excellent prognosis 3

Quantification Systems

Fisher Grading Scale

The Fisher classification quantifies SAH severity on non-contrast CT 2:

  • Fisher Grade 1: No subarachnoid blood detected 2
  • Fisher Grade 2: Diffuse or vertical layers <1 mm thick 2
  • Fisher Grade 3: Localized clot or vertical layers ≥1 mm thick 2
  • Fisher Grade 4: Intracerebral or intraventricular clot with diffuse or no subarachnoid blood 2

*Note: "Vertical" hemorrhage cisterns include interhemispheric, insular, and ambient cisterns 2

Temporal Evolution on CT

Subacute Phase (1-6 weeks)

  • Blood may appear as layering of red blood cells in dependent locations 2
  • Common sites include occipital horns of lateral ventricles, dorsal margins of Sylvian fissures, and sulci of cerebral convexities 2
  • Blood density may become isodense, hypodense, or mixed density compared to adjacent brain tissue 2

Chronic Phase (>6 weeks)

  • CT becomes less sensitive; hemoglobin degradation products are better visualized on MRI 2

Critical Diagnostic Pitfalls

Time-Dependent Sensitivity

  • CT sensitivity decreases significantly after 6 hours from symptom onset 4
  • Beyond 6 hours, lumbar puncture becomes mandatory when CT is negative 4
  • Within 6 hours, high-quality third-generation CT interpreted by experienced neuroradiologists may obviate lumbar puncture in typical presentations 4

Pseudo-Subarachnoid Hemorrhage

  • Hyperdensity in basal cisterns can occur without true SAH in conditions causing diffuse cerebral edema or increased intracranial pressure 5
  • Absence of aneurysm on vascular imaging and autopsy confirmation of no hemorrhage distinguishes this entity 5
  • Consider this diagnosis when vascular imaging is negative despite apparent SAH on CT 5

Distinguishing from Other Hemorrhage Types

Key differentiating features:

  • Epidural hematoma: Occurs between skull and dura mater, does not follow sulci/gyri 1
  • Subdural hematoma: Occurs between dura and arachnoid, does not follow sulci/gyri contour 1
  • Intraparenchymal hemorrhage: Focal collection within brain parenchyma, not in subarachnoid space 1
  • Intraventricular hemorrhage: Blood confined to ventricular system 1

Clinical Context and Next Steps

When CT Shows SAH

  • Proceed immediately with CT angiography or catheter angiography to identify bleeding source, even with minimal visible blood 4
  • CTA has 96.5% sensitivity and 88% specificity for aneurysms overall, but limited sensitivity for aneurysms <3 mm 4, 6
  • If CTA is negative but SAH confirmed, perform digital subtraction angiography with 3D rotational angiography (>98% sensitivity and specificity) 4

When CT is Negative but Clinical Suspicion High

  • Do not dismiss negative CT in high-risk presentations including thunderclap headache, photophobia, neck stiffness, or exertional onset 4
  • Perform lumbar puncture looking for xanthochromia (100% sensitivity, 95.2% specificity when performed 12 hours to 2 weeks after onset) 1, 4
  • Atypical presentations (primary neck pain without headache, syncope, new seizure, focal deficits) mandate full workup despite negative imaging 4

Associated Findings Suggesting Secondary Causes

  • Radiologic red flags for underlying vascular lesions include: 2
    • Subarachnoid hemorrhage with unusual (non-circular) hematoma shape 2
    • Edema disproportionate to early timing of imaging 2
    • Unusual hemorrhage location 2
    • Presence of other abnormal structures like masses 2
    • Abnormal signal in cerebral sinuses (consider venous thrombosis) 2

References

Guideline

Subarachnoid Hemorrhage Diagnosis and Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach and Management of Subarachnoid Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Subarachnoid Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.